In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa

被引:94
作者
Lampronti, I
Martello, D
Bianchi, N
Borgatti, M
Lambertini, E
Piva, R
Jabbar, S
Choudhuri, ASK
Khan, ATH
Gambari, R
机构
[1] Univ Ferrara, Dipartimento Biochim & Biol Mol, I-44100 Ferrara, Italy
[2] Univ Sci & Technol Chittagong, Fac Pharmaceut Sci, Pharmacol Res Lab, Chittagong, Bangladesh
[3] Univ Ferrara, Ctr Biotechnol, Lab Dev Pharmacol & Pharmacogenom Therapy Thalass, I-44100 Ferrara, Italy
关键词
Aegle marmelos; antiproliferative activity; anticancer agents; medicinal plants;
D O I
10.1078/094471103322004794
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
In the present paper we show that extracts from Aegle marmelos Correa are able to inhibit the in vitro proliferation of human tumor cell lines, including the leukemic K562, T-lymphoid Jurkat, B-lymphoid Raji, erythroleukemic HEL, melanoma Colo38, and breast cancer MCF7 and MDA-MB-231 cell lines. Molecules present within the studied Aegle marmelos C. extracts were identified by gas-chromatography/mass-spectrometry analysis; three derivatives (butyl p-tolyl sulfide, 6-methyl-4-chromanone and butylated hydroxyanisole) were found to exhibit strong. activity in inhibiting in vitro cell growth of human K562 cells. The antiproliferative activity of these compounds was found to be comparable to that of known antitumor agents, including cisplatin, chromomycin, cytosine arabinoside and 5-fluorouracil. In addition, the antiproliferative activity of butyl-p-tolyl sulfide, 6-methyl-4-chromanone and 5-methoxypsolaren was associated to activation of the differentiation pattern of K562 cells.
引用
收藏
页码:300 / 308
页数:9
相关论文
共 58 条
[1]  
Abo K A, 2000, Afr J Med Med Sci, V29, P325
[2]   Screening of some Indian medicinal plants for their antimicrobial properties [J].
Ahmad, I ;
Mehmood, Z ;
Mohammad, F .
JOURNAL OF ETHNOPHARMACOLOGY, 1998, 62 (02) :183-193
[3]   Yucatec Mayan medicinal plants: evaluation based on indigenous uses [J].
Ankli, A ;
Heinrich, M ;
Bork, P ;
Wolfram, L ;
Bauerfeind, P ;
Brun, R ;
Schmid, C ;
Weiss, C ;
Bruggisser, R ;
Gertsch, J ;
Wasescha, M ;
Sticher, O .
JOURNAL OF ETHNOPHARMACOLOGY, 2002, 79 (01) :43-52
[4]  
BAGULEY BC, 1982, MOL CELL BIOCHEM, V43, P167
[5]   Accumulation of γ-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine [J].
Bianchi, N ;
Chiarabelli, C ;
Borgatti, M ;
Mischiati, C ;
Fibach, E ;
Gambari, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) :951-961
[6]   Induction of erythroid differentiation of human K562 cells by cisplatin analogs [J].
Bianchi, N ;
Ongaro, F ;
Chiarabelli, C ;
Gualandi, L ;
Mischiati, C ;
Bergamini, P ;
Gambari, R .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (01) :31-40
[7]   Pharmacogenomic analysis: Correlating molecular substructure classes with microarray gene expression data [J].
Blower P.E. ;
Yang C. ;
Fligner M.A. ;
Verducci J.S. ;
Yu L. ;
Richman S. ;
Weinstein J.N. .
The Pharmacogenomics Journal, 2002, 2 (4) :259-271
[8]   Cytotoxic constituents of the stem bark of Neolitsea acuminatissima [J].
Chang, FR ;
Hsieh, TJ ;
Huang, TL ;
Chen, CY ;
Kuo, RY ;
Chang, YC ;
Chiu, HF ;
Wu, YC .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (03) :255-258
[9]   Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells [J].
Chauvier, D ;
Morjani, H ;
Manfait, M .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (02) :113-125
[10]   Microarrays in pharmacogenomics - advances and future promise [J].
Chicurel, ME ;
Dalma-Weiszhausz, DD .
PHARMACOGENOMICS, 2002, 3 (05) :589-601